澳大利亚采购需求：DLBCL 治疗方案、DLBCL 预后、DLBCL 生存率、DLBCL 风险因素、DLBCL 临床试验、DLBCL 免疫疗法
原文：DLBCL treatment options, DLBCL prognosis, DLBCL survival rates, DLBCL risk factors, DLBCL clinical trials, DLBCL immunotherapy
参考产品图片：
-
Facebook
-
澳大利亚
- 2025-08-11
-
zacharygeo****@****l.com
- 048****824
采购商询盘内容
I'm seeking information regarding my health condition diagnosed in May 2025. This is my third battle with double large B cell lymphoma, and I have limited CD3 and CD19/20 cells. Can CART T-cell therapy still be effective for me? Also, is there a possible way to boost my body's production of these particular cells?
Additionally, I would like to know if I might be eligible for a stem cell transplant. Any insights or guidance you can provide on these matters would be greatly appreciated. Thank you!
我正在寻求关于我2025年5月确诊的健康状况的信息。这是我第三次与双大B细胞淋巴瘤抗争，我的CD3和CD19/20细胞数量有限。CART T细胞疗法对我还能有效吗？另外，有没有可能的方法可以促进我的身体产生这些特定的细胞？
此外，我想知道我是否有资格接受干细胞移植。如果您能提供任何关于这方面的见解或指导，我将不胜感激。谢谢！
注册免费获取联系方式（剩余查看次数3）